The Department of Health and Social Care (DHSC) has confirmed that the reimbursement price for the following product in Part VIII of the Drug Tariff has been redetermined, in the months as set out in the table, to reflect an increase in the NHS list price of the reference product:
|
Product |
Pack size |
Old NHS list price |
New NHS list price |
Part VIIIA Category |
Month |
|---|---|---|---|---|---|
|
Macrogol 3350 oral powder 8.5g sachets sugar free |
28 |
£164.21 |
£188.84 |
C (based on TransiSoft) |
March 2025 |
DHSC has also confirmed that the reimbursement prices for the following branded products have been redetermined, in the months as set out in the table, to reflect an increase in the NHS list price, as detailed below:
|
Product |
Pack size |
Old list price |
New list price |
Month(s) |
|---|---|---|---|---|
|
Affenid XL 18mg tablets (Zentiva Pharma UK Ltd) |
30 |
£10.90 |
£13.08 |
March 2025 |
|
Affenid XL 27mg tablets (Zentiva Pharma UK Ltd) |
30 |
£12.87 |
£15.44 |
March 2025 |
|
Affenid XL 36mg tablets (Zentiva Pharma UK Ltd) |
30 |
£14.85 |
£17.82 |
March 2025 |
|
Affenid XL 54mg tablets (Zentiva Pharma UK Ltd) |
30 |
£25.75 |
£30.90 |
March 2025 |
|
TransiSoft oral powder 8.5g sachets (Mayoly UK Ltd) |
28 |
£164.21 |
£188.84 |
March 2025 |
|
Vistamethasone 0.1% ear/eye/nose drops (Martindale Pharmaceuticals Ltd) |
5ml |
£7.00 |
£11.30 |
March 2025 |
Payment after the relevant dates (as set out in the tables) will be as per Clause 8 (Basic Price of Drugs), Part II of the Drug Tariff.